Answers are grounded in this paper and cite their sources.
Digital transformation of healthcare systems including artificial intelligence (AI) technologies and clinical decision-making support systems (CDSS) became popular worldwide. There is a growing need for early diagnosis and treatment of cardiovascular diseases with personalized approach to these issues. We reviewed appropriate foreign and domestic digital solutions in clinical practice. CDSS is valuable for physicians to receive a digitalized cardiovascular status and “hints” about the patient’s risks, examination and treatment in accordance with clinical guidelines considering absolute and relative contraindications, as well as AI-predicted missing important parameters. The doctor is able to choose the most effective and safe drug considering clinical trials and network meta-analysis in CDSS functionality. CDSS analytical dashboards allow the attending physician and healthcare organizer to automate dispensary follow-up by selecting patients with unmet health targets and assess the quality of care. CDSS-based automatic assessment of indications for drugs according to clinical recommendations allows planning preferential drug provision. CDSS has a potential to improve physician adherence to clinical guidelines and facilitate selection of personalized therapy for patients with cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Shangina et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: